title: SOP 09: Statistical design and analysis.
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards / Q000706:statistics & numerical data; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards* / Q000706:statistics & numerical data*; D017321:Clinical Trials, Phase I as Topic / Q000592:standards / Q000706:statistics & numerical data; D017322:Clinical Trials, Phase II as Topic / Q000592:standards / Q000706:statistics & numerical data; D017326:Clinical Trials, Phase III as Topic / Q000592:standards / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D023381:Endpoint Determination / Q000592:standards / Q000706:statistics & numerical data; D005060:Europe; D019983:Guideline Adherence / Q000592:standards; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic / Q000592:standards / Q000706:statistics & numerical data
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational